FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging

Table 3 Relation between FAT10 expression and clinicopathologic factors for gastric cancer

Clinic pathologic factors	Samples	FAT10 positive samples (%)	χ2	P
Age (yr)
< 50	19	7 (36.84)	2.39	> 0.05
≥ 50	43	25 (58.14)
Gender
Male	38	19 (50.00)	0.1	> 0.05
Female	24	13 (54.16)
Tumor size (cm)
< 5	33	16 (48.48)	0.28	> 0.05
≥ 5	29	16 (55.17)
Location
Antrum	31	15 (48.39)	2.81	> 0.05
Angle	5	2 (40.00)
Body	14	9 (64.29)
Fundus	4	3 (75.00)
Cardia	8	3 (37.50)
Progression degree
Early stage	11	6 (54.54)	0.05	> 0.05
Progressive stage	51	26 (50.98)
Differentiation degree
High, middle	15	7 (46.67)	0.19	> 0.05
Low, none	47	25 (53.19)
Lymph metastasis
Positive	39	25 (64.10)	6.57	< 0.05
Negative	23	7 (30.43)
Distant metastasis
Positive	15	11 (73.33)	3.74	> 0.05
Negative	47	21 (44.68)
TNM Staging
I + II	21	7 (33.33)	4.25	< 0.05
III + IV	41	25 (60.98)